Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features

OBJECTIVE: The use of a neoadjuvant chemoradiation followed by surgery in patients with stage IIIA NSCLC is controversial and the benefit of surgery is limited. There are currently no clinically validated biomarkers to select patients for such an approach. In this study we evaluate computed tomograp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lung Cancer
Main Authors: Khorrami, Mohammadhadi, Jain, Prantesh, Bera, Kaustav, Patil, Pradnya, Ahmad, Usman, Murthy, Sudish, Stephans, Kevin, Fu, Pingfu, Velcheti, Vamsidhar, Madabhushi, Anant
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6711393/
https://ncbi.nlm.nih.gov/pubmed/31446979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2019.06.020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados